Atrium Therapeutics, Inc. RNA

Full chart Compare
Set alert

Price alert · RNA

All alert types
8.70 USD -0.02 (-0.28%)

Nov 4, 2026, 1:06 PM EST

8.50 Day range 8.90
7.49 52-week range 16.77
YTD
-41.05%
1 year
-41.05%

Upgrades and downgrades

The latest rating changes

RNA analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2025Chardan CapitalMaintainedNeutralNeutral
Oct 29, 2025TD CowenDowngradeBuyHold
Oct 28, 2025Chardan CapitalDowngradeBuyNeutral
Oct 28, 2025RBC CapitalDowngradeOutperformSector Perform
Oct 27, 2025CitigroupDowngradeBuyNeutral
Oct 27, 2025Leerink PartnersDowngradeOutperformMarket Perform
Oct 27, 2025Raymond JamesDowngradeStrong BuyMarket Perform
Oct 27, 2025BernsteinDowngradeOutperformMarket Perform
Oct 27, 2025NeedhamDowngradeBuyHold
Oct 27, 2025HC Wainwright & Co.DowngradeBuyNeutral
Sep 22, 2025Evercore ISI GroupMaintainedOutperformOutperform
Sep 17, 2025Roth CapitalInitiated—Buy
Sep 15, 2025B of A SecuritiesMaintainedBuyBuy
Sep 12, 2025HC Wainwright & Co.MaintainedBuyBuy
Sep 10, 2025NeedhamMaintainedBuyBuy
Sep 10, 2025Chardan CapitalMaintainedBuyBuy
Aug 8, 2025Wells FargoMaintainedOverweightOverweight
Aug 8, 2025BarclaysMaintainedOverweightOverweight
Aug 8, 2025Chardan CapitalMaintainedBuyBuy
Jun 27, 2025Cantor FitzgeraldReiteratedOverweightOverweight
Jun 17, 2025Wolfe ResearchInitiated—Outperform
Jun 11, 2025Raymond JamesInitiated—Strong Buy
Jun 10, 2025CitigroupMaintainedBuyBuy
Jun 10, 2025BarclaysMaintainedOverweightOverweight
Jun 9, 2025B of A SecuritiesMaintainedBuyBuy
Jun 9, 2025Chardan CapitalMaintainedBuyBuy
May 12, 2025HC Wainwright & Co.MaintainedBuyBuy
May 9, 2025Chardan CapitalMaintainedBuyBuy
May 7, 2025Chardan CapitalMaintainedBuyBuy
Apr 9, 2025NeedhamReiteratedBuyBuy